ROBERT N. POWER - Corporate Board Profile

Bausch Health Companies Inc.

Filing Date	Source Excerpt
2015-04-09	Mr. Power has been serving on the Board of the Company since August 2008. ... Committee Membership and Meeting Attendance: Board - 29/29; Nominating and Corporate Governance Committee - 13/13; Talent and Compensation Committee - 18/18. ... Director Compensation: Fees Earned or Paid in Cash($): 105,729; Stock Awards($): 382,496; Total($): 488,225.
2016-04-29	Mr. Power has been serving on the Board since August 2008. Mr. Power was a faculty member at The Wharton School of Business, University of Pennsylvania, where he taught multinational marketing from 2009 to 2011.
2017-03-23	Mr. Power has been serving on the Board since August 2008. The Board has determined that Mr. Power’s extensive experience in the pharmaceutical industry and international business is a valuable contribution to the Board. In addition, his experience in general management, strategic planning, working with R&D organizations, business development, product marketing, merging and streamlining of organizations and his demonstrated leadership in a multi-billion dollar business qualify Mr. Power as a member of the Board and the committees on which he sits.
2018-03-21	Mr. Robert N. Power Pennsylvania, USA Age 61 Independent 6,601 Common Shares — $101,655 51,627 RSUs (comprised of 26,221 vested RSUs — $403,803 and 25,406 unvested RSUs — $391,252) No Options Total Equity Value at Risk: $505,459, representing 101% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-management Directors and 505% of the Director’s annual retainer. 2017 Meeting Attendance: Board — 8/8; Audit and Risk Committee — 10/10; Nominating and Corporate Governance Committee — 6/6. Director Compensation Table: Robert N. Power Fees Earned or Paid in Cash ($): 125,885 Stock Awards ($): 249,995 All Other Compensation ($): — Total ($): 375,880
2019-03-18	Mr. Robert N. Power Age 62 Independent 2018 Meeting Attendance: Board 5/5 Audit and Risk Committee 8/8 Nominating and Corporate Governance Committee 4/4 Director Compensation Table: Robert N. Power Fees Earned or Paid in Cash: 132,152 Stock Awards: 250,000 All Other Compensation: 0 Total: 382,152
2020-03-16	Mr. Robert N. Power Age 63 Independent 2019 Meeting Attendance: Board 6/6, Audit and Risk Committee 8/8, Nominating and Corporate Governance Committee 4/4, Science and Technology Committee 4/4. Director Compensation Table: Fees Earned or Paid in Cash $142,500, Stock Awards $250,000, Total $392,500.
2021-03-18	Robert N. Power Pennsylvania, USA Age 64 Independent Stock Ownership: 6,601 Common Shares $209,582 87,178 RSUs (comprised of 76,141 vested RSUs $2,417,477, and 11,037 unvested RSUs $350,425) Total Equity Value at Risk: $2,627,059, representing 525% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-employee Directors and 2,627% of the annual Board retainer. 2020 Meeting Attendance: Board 9/9 Audit and Risk Committee 9/9 Nominating and Corporate Governance Committee 4/4 Science and Technology Committee 6/6
2022-05-02	Mr. Power has served on the Board since August 2008. ... 2021 Meeting Attendance: Board 8/8, Audit and Risk Committee 10/10, Nominating and Corporate Governance Committee 10/10, Science and Technology Committee 5/5.
2023-04-06	Mr. Power has served on the Board since August 2008. He is currently a corporate director. From 2009 to 2011, Mr. Power was a faculty member at The Wharton School of Business, University of Pennsylvania, where he taught multinational marketing. Mr. Power has over 25 years’ experience working in the pharmaceutical and biotechnology industry, which he gained serving in a number of leadership positions with Wyeth from 1985 through 2007, including Director — New Product Development, Managing Director — U.K./Ireland, Vice President — Global Marketing, President — Europe, Middle East, Africa, President — International and Executive Vice President — Global Business Operations. Mr. Power also has completed the Director Professionalism course offered by the National Association of Corporate Directors. Mr. Power has a B.S. in statistics from the State University of New York and an M.S. in biostatistics from the Medical College of Virginia-Virginia Commonwealth University. Qualifications: The Board has determined that Mr. Power’s extensive experience in the pharmaceutical industry and international business is a valuable contribution to the Board. In addition, his experience in general management, strategic planning, working with Research and Development organizations, business development, product marketing, merging and streamlining of organizations and his demonstrated leadership in a multi-billion-dollar business qualify Mr. Power as a member of the Board and the committees on which he serves.
2024-04-04	Mr. Power has served on the Board since August 2008. He is currently a corporate director. From 2009 to 2011, Mr. Power was a faculty member at The Wharton School of Business, University of Pennsylvania, where he taught multinational marketing. Mr. Power has over 25 years’ experience working in the pharmaceutical and biotechnology industry, which he gained serving in a number of leadership positions with Wyeth from 1985 through 2007, including Director — New Product Development, Managing Director — U.K./Ireland, Vice President — Global Marketing, President — Europe, Middle East, Africa, President — International and Executive Vice President — Global Business Operations. Mr. Power also has completed the Director Professionalism course offered by the National Association of Corporate Directors. Mr. Power has a B.S. in statistics from the State University of New York and an M.S. in biostatistics from the Medical College of Virginia- Virginia Commonwealth University. Stock Ownership: 6,601 Common Shares — $60,729; 158,415 RSUs (comprised of 129,210 vested RSUs — $1,888,732, and 29,205 unvested RSUs — $268,686). Total Equity Value at Risk: $1,249,461, representing 250% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-employee Directors and 1,249% of the annual Board retainer. 2023 Meeting Attendance: Board: 8/8; Audit & Risk Committee: 1/1; Nominating & Corporate Governance Committee: 5/5; Talent & Compensation Committee: 4/4. The Board has determined that Mr. Power’s extensive experience in the pharmaceutical industry and international business is a valuable contribution to the Board. In addition, his experience in general management, strategic planning, working with Research and Development organizations, business development, product marketing, merging and streamlining of organizations and his demonstrated leadership in a multi-billion-dollar business qualify Mr. Power as a member of the Board and the committees on which he serves.
2025-04-02	Mr. Power has served on the Board since August 2008. ... Committees: Talent & Compensation Committee (Chair), Nominating & Corporate Governance Committee. ... Director Compensation Table shows total compensation of $387,500.